AIOLOS, NCT05344469: A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis |
|
|
| Recruiting | N/A | 800 | Europe | ofatumumab, glatiramer acetate, interferon β1 | Novartis Pharmaceuticals | Relapsing Multiple Sclerosis | 12/26 | 12/26 | | |
NCT05688436: A Study to Assess Pregnancy Outcomes in Women Exposed to Diroximel Fumarate |
|
|
| Recruiting | N/A | 1178 | US | Diroximel Fumarate, VUMERITY, BIIB098, Alemtuzumab, Fingolimod, Glatiramer acetate, Interferon beta, Natalizumab, Tysabri, BG00002, Ocrelizumab, Ofatumumab, Ozanimod, Peginterferon beta-1a, Ponesimod, Siponimod | Biogen | Multiple Sclerosis | 01/31 | 01/31 | | |
